A company insider recently bought 1,244 shares of CME Group Inc. [CME]. Should You Buy?


The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CME Group Inc. shares valued at $218,906 were purchased by SHEPARD WILLIAM R on Jan 18. At $175.98 per share, SHEPARD WILLIAM R acquired 1,244 shares. The insider’s holdings grew to 249,376 shares worth approximately $45.37 million following the completion of this transaction.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Also, SHEPARD WILLIAM R purchased 55 shares, netting a total of over 9,651 in proceeds. Following the buying of shares at $175.98 each, the insider now holds 2,212 shares.

Before that, SHEPARD WILLIAM R had added 289 shares to its account. In a trade valued at $48,645, the Director bought CME Group Inc. shares for $168.11 each. Upon closing the transaction, the insider’s holdings increased to 289 shares, worth approximately $45.14 million.

As published in a research note from Credit Suisse on January 05, 2023, CME Group Inc. [CME] has been rated up from a Neutral to an Outperform and the price target has been revised to $191. This represents a 4.75% premium over Wednesday’s closing price. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid October. As of October 12, 2022, Citigroup has initiated its “Buy” rating for CME. Earlier on August 17, 2022, Rosenblatt initiated its rating. Their recommendation was “a Sell” for CME stock.

Analyzing CME Stock Performance

On Wednesday, CME Group Inc. [NASDAQ: CME] plunged -0.16% to $181.92. The stock’s lowest price that day was $180.405, but it reached a high of $183.085 in the same session. During the last five days, there has been a drop of approximately -1.25%. Over the course of the year, CME Group Inc. shares have jumped approximately 8.18%. Shares of the company reached a 52-week high of $189.63 on 02/09/23 and a 52-week low of $166.54 on 01/03/23. A 50-day SMA is recorded $178.69, while a 200-day SMA reached $186.60. Nevertheless, trading volume fell to 1.27 million shares from 1.7 million shares the previous day.

Support And Resistance Levels for CME Group Inc. (CME)

According to the 24-hour chart, there is a support level at 180.52, which, if violated, would cause prices to drop to 179.12. In the upper region, resistance lies at 183.20. The next price resistance is at 184.48. RSI (Relative Strength Index) is 47.35 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.76, which suggests the price will decrease in the coming days. Percent R is at 83.21%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is CME Group Inc. subject to short interest?

Stocks of CME Group Inc. saw a sharp steep in short interest on Jan 30, 2023 dropping by -0.49 million shares to 3.61 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2022 was 4.1 million shares. A decline of -13.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.91 of the overall float, the days-to-cover ratio (short ratio) decline to 1.91.

Which companies own the most shares of CME Group Inc. (CME)?

According to The Vanguard Group, Inc. filings, the company currently owns 31,612,280 shares, which is about 8.79% of the total CME shares outstanding. The investor’s shares have appreciated by 340,982 from its previous 13-F filing of 31271298.0 shares. With the completion of the buy transaction, BlackRock Fund Advisors’s stake is now worth $3,008,963,040. SSgA Funds Management, Inc. acquire a 1.25% interest valued at $2.8 billion while Capital Research & Management Co sold a -15,554,066 stake. A total of 27,057 shares of CME Group Inc. were sold by Capital Research & Management Co during the quarter, and 2,751,862 were bought by JPMorgan Investment Management, I. In its current portfolio, Geode Capital Management LLC holds 6,976,560 shares valued at $1.23 billion.

In terms of CME Group Inc. share price expectations, FactSet research, analysts set an average price target of $199.27 in the next 12 months, up nearly 10.31% from the previous closing price of $182.22. Analysts anticipate CME Group Inc. stock to reach $250.00 by 2023, with the lowest price target being $155.00. In spite of this, 20 analysts ranked CME Group Inc. stock as an Overweight at the end of 2023.


Please enter your comment!
Please enter your name here